Trials / Completed
CompletedNCT04210622
An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System
An Initial Assessment of the Safety and Performance of the Sphere-9™ Catheter and System for Mapping and Ablation of Atrial Arrhythmias
- Status
- Completed
- Phase
- —
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, single-arm, multi-center, safety and performance assessment of the Sphere-9™ Catheter and the Affera Mapping and Ablation System to treat Atrial Arrhythmias
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System | Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2019-07-04
- Completion
- 2020-06-18
- First posted
- 2019-12-26
- Last updated
- 2025-05-16
- Results posted
- 2025-05-16
Locations
1 site across 1 country: Lithuania
Source: ClinicalTrials.gov record NCT04210622. Inclusion in this directory is not an endorsement.